Number of centers |
|
3 |
71 |
86 |
Recruitment
period
|
|
2011-2013 |
2012-2016 |
2016-2018 |
Valve Type |
|
CoreValve, Evolut R, or Evolut PRO |
Sapien 3 |
CoreValve |
sample size |
TAVI |
145 |
496 |
725 |
|
SAVR |
135 |
454 |
678 |
male -no. (%) |
TAVI |
78(53.8) |
335(67.5) |
464(64.0) |
|
SAVR |
71(52.6) |
323(71.1) |
449(66.2) |
Mean year |
TAVI |
79.2±4.9 |
73.3±5.8 |
74.1±5.8 |
|
SAVR |
79±4.7 |
73.6±6.1 |
73.6±5.9 |
Mean STS-PROM score |
TAVI |
2.9±1.6 |
1.9±0.7 |
1.9±0.7 |
|
SAVR |
3.1±1.7 |
1.9±0.6 |
1.9±0.7 |
Prior cerebrovascular accident -no. (%) |
TAVI |
24 (16.6) |
17 (3.4) |
74 (10.2) |
|
SAVR |
22 (16.3) |
23 (5.1) |
80 (11.8) |
Prior myocardial infarction -no. (%) |
TAVI |
8 (5.5) |
28 (5.7) |
48
(6.6) |
|
SAVR |
6 (4.4) |
26 (5.8) |
33 (4.9) |
Peripheral vascular disease -no. (%) |
TAVI |
6 (4.1) |
34 (6.9) |
54
(7.5) |
|
SAVR |
9 (6.7) |
33 (7.3) |
56 (8.3) |
Chronic lung disease
-no. (%)
|
TAVI
|
17 (11.7)
|
25 (5.1)
|
104 (15.0)
|
|
SAVR |
16 (11.9) |
28 (6.2) |
117 (18.0) |
Diabetes mellitus
-no. (%)
|
TAVI
|
26 (17.9)
|
155 (31.2)
|
228 (31.4)
|
|
SAVR |
28 (20.7) |
137 (30.2) |
207 (30.5) |
Creatinine level
>2 mg/dl -no. (%)
|
TAVI
|
2 (1.4)
|
1 (0.2)
|
3 (0.4)
|
|
SAVR |
1 (0.7) |
1 (0.2) |
1 (0.1) |
TAVI: transcatheter aortic valve implantation |
TAVI: transcatheter
aortic valve implantation |
TAVI: transcatheter aortic valve
implantation |
TAVI: transcatheter aortic valve implantation |
TAVI:
transcatheter aortic valve implantation |
SAVR: surgical aortic valve replacement |
SAVR: surgical aortic valve
replacement |
SAVR: surgical aortic valve replacement |
SAVR: surgical
aortic valve replacement |
SAVR: surgical aortic valve
replacement |